Growth, IGF System, and Cortisol in Children with Intrauterine Growth Retardation: Is Catch-up Growth Affected by Reprogramming of the Hypothalamic-Pituitary-Adrenal Axis?
- 1 January 2002
- journal article
- Published by Springer Nature in Pediatric Research
- Vol. 51 (1) , 94-99
Abstract
Intrauterine growth retardation (IUGR) is one of the major causes of short stature in childhood. Although postnatal catch-up growth occurs in the majority of IUGR children, approximately 20% of them remain permanently short. The mechanisms that allow catch-up growth or, on the contrary, prevent IUGR children from achieving a normal height are still unknown. Our aim was to investigate whether intrauterine reprogramming of hypothalamic-pituitary-adrenal axis may be involved in postnatal growth retardation of IUGR children through a modulation of the function of the IGF system. Anthropometry, IGF system assessment, cortisol measurement, and lipid profile evaluation were performed in 49 IUGR children. Children were subdivided into two groups according to their actual height corrected for midparental height: CG (catch-up growth) group, 19 children with corrected height ≥0 z-score; and NCG (noncatch-up growth) group, 30 subjects with corrected height 3.4 mM (130 mg/dL). LDL cholesterol was inversely related to birth weight (r = −0.31, p < 0.05), corrected stature (r = −0.32, p < 0.05), and actual height (r = −0.31, p < 0.05) and directly related to the levels of IGF2R (r = 0.44, p < 0.01). Reanalysis of 15 of 30 IUGR newborns in whom we previously reported an inverse relationship between cord blood cortisol levels and first trimester length gain (r = −0.54, p < 0.005) showed that the relative amount of the IGFBP-3 18-kD fragment was related inversely to cortisol (r = −0.67, p < 0.01) and directly to early postnatal growth (r = 0.65, p < 0.05). Our results suggest that catch-up growth in IUGR children might be affected by intrauterine reprogramming of hypothalamic-pituitary-adrenal axis, which may result in a permanent modification of the neuroendocrine response to stress: children with increased cortisol secretion may be at higher risk of growth failure. During the neonatal period cortisol might act by limiting IGFBP-3 proteolysis and, therefore, reducing IGF bioavailability.Keywords
This publication has 46 references indexed in Scilit:
- Body Composition, Blood Pressure, and Lipid Metabolism before and during Long-Term Growth Hormone (GH) Treatment in Children with Short Stature Born Small for Gestational Age Either with or without GH DeficiencyThe Journal of Clinical Endocrinology & Metabolism, 2000
- Can Excess Glucocorticoid, in Utero, Predispose to Cardiovascular and Metabolic Disease in Middle Age?Trends in Endocrinology & Metabolism, 1999
- Regulation of Soluble Insulin-Like Growth Factor II/Mannose 6-Phosphate Receptor in Human Serum: Measurement by Enzyme-Linked Immunosorbent AssayThe Journal of Clinical Endocrinology & Metabolism, 1999
- Insulin-like growth factor-binding protein-1 expression in cultured human bone cells: regulation by insulin and glucocorticoidEndocrinology, 1996
- Soluble insulin-like growth factor-II/mannose 6-P receptor inhibits deoxyribonucleic acid synthesis in cultured rat hepatocytesEndocrinology, 1996
- Transcriptional repression of insulin-like growth factor I by glucocorticoids in rat bone cellsEndocrinology, 1995
- Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age childrenThe Journal of Clinical Endocrinology & Metabolism, 1995
- Does growth hormone treatment improve final height attainment of children with intrauterine growth retardation?Archives of Disease in Childhood, 1991
- Growth Hormone Secretion and Growth Hormone Treatment in Children with Intrauterine Growth RetardationActa Paediatrica, 1989
- Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty.Archives of Disease in Childhood, 1976